Acceptability and tolerability of new brand injectable product based on hyaluronic acid for lip rejuvenation Rennova Lips®

Abstract

Currently, with the greater importance given to self-image, particularly with the phenomenon of “selfies,” the facial aesthetics segment has become more widely exposed, and with it, the shape, size and contour of the lips has gained greater prominence, leading more and more patients to seek to improve or correct features to reach the aspect considered ideal for the lip area, both in the media and among the general public. Many alloplastic products, both topical and injectable, are touted by the pharmaceutical industry for this purpose. The application of hyaluronic acid-based injectable products have the fewest adverse effects, being highly studied and with well-defined techniques for use. In this study, the hyaluronic acid product Rennova Lips®, recommended for use on the lips, was used, followed by an observation of its tolerability and acceptability. The satisfactory maintenance of results after 12 months of the procedure was noted, as well as low rates of adverse effects, qualifying the product for this indication.